Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

PAD regimen

View Patient Information
A chemotherapy regimen containing bortezomib, doxorubicin and dexamethasone regimen used in the treatment of plasma cell myeloma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:bortezomib-doxorubicin-dexamethasone regimen
bortezomib/ dexamethasone/doxorubicin
bortezomib/doxorubicin/dexamethasone regimen
PS-341/Adriamycin/dexamethasone regimen
Velcade/adriamycin/dexamethasone regimen
Abbreviation:PAD
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search